Navin Fluorine International Limited · NSE:NAVINFLUOR
Navin Fluorine International — Q4 FY16 Earnings Presentation
21 slides from Navin Fluorine International's earnings presentation, 2016
Slide 1: Result Update Presentation Q4 FY16 & FY16
Navin Fluorine International Limited Result Update Presentation Q4 FY16 & FY16
Slide 2: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 3: Growth Journey Gains Momentum
Growth Journey Gains Momentum 53% 87% Net Profit 63% Operating Rs. 84 Crs PBT 15% Operating Rs. 91 Crs EBITDA Revenue Rs. 117 Crs Rs. 680 Crs Growth driven by Business-Mix, Product-Mix & Operating Efficiencies 3 Note: Consolidated FY16 Results compared with Consolidated FY15
Slide 4: CRAMS: Scaling-Up through Innovation
CRAMS : Scaling-Up through INNOVATION Rs. 131 Crs Rs. 80 Crs Rs. 68 Crs Rs. 40 Crs FY13 FY14 FY15 FY16 Leveraging our proven skills Developed India’s Only High Relationship with in Fluorination Chemistry Pressure Fluorination, cGMP “FORTUNE 500” Compliant Capabilities CLIENTELE 4 Note : CRAMS Consol
Slide 5: Revenue Mix: Business Unit Wise
Revenue Mix : Business Unit Wise 6% 14% 11% 16% 23% 39% 39% 38% 37% 34% 19% 14% 17% 17% 12% 36% 34% 33% 30% 31% FY15 FY16 Q4 FY15 Q3 FY16 Q4 FY16 CRAMS Specialty Chemicals Inorganic Fluorides Refrigerant Gases 5 * Standalone Results
Slide 6: Business Units Performance: Refrigerants, Inorganic Fluorides
Business Units Performance Refrigerants Inorganic Fluorides Revenue (Rs.Crs) 215 113 105 195 194 98 99 94 176 154 FY12 FY13 FY14 FY15 FY16 FY12 FY13 FY14 FY15 FY16 Exports 11% Exports Geographic Mix – FY16 38% Domestic 62% Domestic 89% 6 * Standalone Results
Slide 7: Business Units Performance: Specialty Chemicals, CRAMS
Business Units Performance Specialty Chemicals CRAMS** Revenue (Rs.Crs) 239 87 215 178 159 156 26 31 14 FY12 FY13 FY14 FY15 FY16 FY13 FY14 FY15 FY16 Domestic 0% Geographic Mix – FY16 Exports 46% Exports 100% Domestic 54% 7 ** CRAMS business generating revenue since FY13 * Standalone Results
Slide 8: Strategy Begins to Yield Results
Strategy Begins to Yield Results Return on Net Worth (%) Return on Capital Employed (%) 14% 18% 10% 9% 9% 12% 11% 11% FY13 FY14 FY15 FY16 FY13 FY14 FY15 FY16 8 * Standalone Results
Slide 9: Key Updates
Key Updates Manufacturing Facility at Dewas 01 • The new facility is India’s only plant with cGMP compliant capabilities for high pressure fluorination • Numerous Customer Audits completed successfully • Plant commercially operational Greenfield Facility at Dahej, Gujarat 02 • JV with Piramal Enterp
Slide 10: Standalone Profitability Statement
Standalone Profitability Statement Rs. Crs. FY16 FY15 Change % Q4 FY16 Q4 FY15 Change % Revenue 636 546 17% 190 146 30% Raw Material 292 272 88 74 Employee Expenses 66 61 19 15 Other Expenses 162 150 47 38 EBITDA 116 63 83% 36 18 95% EBITDA Margin 18.3% 11.6% 666 bps 18.9% 12.6% 635 bps Interest Exp
Slide 11: Standalone Balance Sheet
Standalone Balance Sheet Rs. Crs. Mar’16 Mar’15 Shareholder’s Fund Share capital 10 10 Reserves & Surplus 624 561 Non-current liabilities Long term borrowings - 12 Deferred Tax Liabilities (net) 36 32 Other non-current liabilities 27 26 Current liabilities Short term borrowings 30 33 Trade Payables
Slide 12: Consolidated Profitability Statement
Consolidated Profitability Statement Rs. Crs. FY16 FY15 Change % Revenue 680 592 15% Raw Material 311 289 Employee Expenses 81 74 Other Expenses 171 156 EBITDA 117 72 63% EBITDA Margin 17.3% 12.2% 506 bps Interest Expenses 4 3 Depreciation 22 20 Operating PBT 91 49 87% Operating PBT Margin 13.4% 8.2
Slide 13: Consolidated Balance Sheet
Consolidated Balance Sheet Rs. Crs. Mar’16 Mar’15 Shareholder’s Fund Share capital 10 10 Reserves & Surplus 636 578 Minority Interest - 13 Non-current liabilities Long term borrowings 48 27 Deferred Tax Liabilities (net) 37 32 Other non-current liabilities 29 28 Current liabilities Short term borrow
Slide 14: Consistent Dividend Performance
Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout Declared Highest ever Total Dividend @ 210% Interim Final Continuous Dividend since last 10 years 160% 160% 150% 150% 150% 140% Special Dividend of Rs. 60 per share in FY 12 Declared Final Dividend of Rs.11 per
Slide 15: Business Overview
Responsible Care” Business Overview rN Wh ARVIND MAFATLAL GROUP
Slide 16: Overview
Overview Built “India’s only plant with high pressure fluorination capabilities with Largest Integrated Specialty cGMP compliance” for CRAMS Business Fluorochemical Company in India Manufacturing plants Over 45 years of expertise strategically located in Handling Fluorine closer to major ports Stron
Slide 17: Business Units (BU) - Standalone
Business Units (BU) - Standalone FY11 – Revenue % FY16 – Revenue % Commenced CRAMS business in 2011 CRAMS – 0% CRAMS – 14% Commenced Specialty Chemicals in Specialty Specialty 2000 Chemicals – 27% Chemicals – 38% Inorganic Fluorides & Inorganic Inorganic Refrigerants are Fluorides – 18% Fluorides –
Slide 18: Clients across the Globe
& e Clients across the Globe Ne ; UJ CLARIANT™ Cs) Bayer syngenta Cs) Bayer CropScience 2. PHARMACEUTICAL anaadl Bem. —_INDUSTRIESLTD. eo LUPIN AUROBINDO ‘Committed to Healthier Life e ae Y Dr.ReDpy's LIFE. RESEARCH . HOPE IN: 18 ARVIND MAFATLAL GROUP
Slide 19: Key Strengths
Key Strengths Fluorination Capabilities In-house R&D Pioneered Manufacturing of State-of-the-art R&D centre – Navin Refrigerant Gases in India Research Innovation Centre at Surat Over 45 years of experience in DSIR approved R&D Centre handling Fluorine Supports in product addition & Exte
Slide 20: Growth driven by Every Business Unit
Growth driven by Every Business Unit CRAMS Business progression from Contract Research to Contract Manufacturing cGMP compliant manufacturing facility operational Specialty Chemicals Introduction of new high value added molecules in portfolio Entry into newer geographies Inorganic Fluorides
Slide 21: Contact
Contact For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Sitendu Nagchaudhuri Ms. Sanjita Ghosh / Mr. Shogun Jain Chief Financial Officer
Navin Fluorine International — Q4 FY16 Earnings Presentation on 6ix